The landmark Randomized Aldactone Evaluation Study (RALES), published in 1999, showed that spironolactone, a potassium-sparing diuretic, improves outcomes in patients with severe heart failure.
Spironolactone is a generic prescription drug ... herein is subject to change and is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic ...
Spironolactone may be unsafe to take while ... herein is subject to change and is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions ...